Search results
Results from the WOW.Com Content Network
Since 1971 the Sandoz brand name has been split into four main areas of production, due to its licences being leased or sold. This has led to four separate brands, Sandoz Singapore, Sandoz Hong Kong, Sandoz Swiss, and Sandoz Spain (Munreco). All of these produce watches under the Sandoz name, but each production company has its own line of ...
In 2002, Sandoz acquired Lek Pharmaceuticals d.d., Slovenia's largest pharmaceutical company. [29] In 2003, Novartis united its global generics businesses under a single global brand, reestablishing the name Sandoz as a division of Novartis. [19] The Amifarma S.L. production plant in Palafolls, located near Barcelona, Spain was also acquired. [19]
The Novartis-owned company said its drug, Hyrimoz, will be priced at a 5% discount off Humira’s current list price of $6,922 per month, but that it was also offering an unbranded version of ...
Clariant AG is a Swiss multinational speciality chemical company, formed in 1995 as a spin-off from Sandoz.Headquartered in Muttenz, Switzerland, [5] the public company encompasses 68 subsidiaries in 36 countries (2023).
The Chemiefirma Kern und Sandoz ("Kern and Sandoz Chemistry Firm") was founded in 1886 by Alfred Kern (1850–1893) and Edouard Sandoz (1853–1928). The first dyes manufactured by them were alizarinblue and auramine. After Kern's death, the partnership became the corporation Chemische Fabrik vormals Sandoz in 1895.
Other Ciba-Geigy and Sandoz businesses were sold off, or, like Ciba Specialty Chemicals, were spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz .
The lawsuit asserts that Novartis subsidiary Sandoz did not apply for a license when it began to sell pirfenidone in the U.S. market. Esbriet had a revenue of $740 million in the U.S. market (2021), and Genentech alleges that Sandoz's unlawful sale of pirfenidone has caused "significant financial harm." [27]
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.